Miltenyi Biomedicine stellt die Primäranalyse der zulassungsrelevanten DALY-2-EU-Studie zur Zweitlinientherapie des rezidivierten/refraktären großzelligen B-Zell-Lymphoms auf der 67. Jahrestagung der American Society of Hematology (ASH) vor
Die Ergebnisse der DALY 2–EU–Studie zeigen, dass Zamtocabtagen Autoleucel (Zamto–cel) bei Patienten mit rezidiviertem/refraktärem großzelligem B–Zell–Lymphom (r/r LBCL) eine klinisch bedeutsame Überlegenheit ...
À l’occasion de la 67e réunion annuelle de l’American Society of Hematology (ASH), Miltenyi Biomedicine présente l’analyse primaire de l’essai pivot DALY 2-EU pour le traitement de seconde ligne du lymphome à grandes cellules B en rechute ou réfractaire
Les résultats de l’essai DALY 2–EU révèlent que le zamtocabtagene autoleucel (zamto–cel) présente une supériorité cliniquement significative par rapport à la chimio–immunothérapie ...
Miltenyi Biomedicine divulga análise primária do estudo principal do DALY 2-EU para linfoma de células B grandes recidivante/refratário de segunda linha na 67ª Reunião Anual da Sociedade Americana de Hematologia (ASH)
Os resultados do DALY 2–UE mostram que o autoleucel de zamtocabtageno (zamto–cel) demonstrou superioridade clinicamente significativa em relação à quimioimunoterapia em pacientes com linfoma de células ...
Cochin Shipyard to build next-generation electric TRAnsverse tugs for Svitzer
Cochin, India and Copenhagen, Denmark – 8 December 2025. Svitzer, a leading global towage provider, and Cochin Shipyard Limited (CSL), India’s largest public sector shipyard, have signed a shipbuilding agreement for four 26–metre ...
Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting
DALY 2–EU results show zamtocabtagene autoleucel (zamto–cel) demonstrated clinically meaningful superiority over chemoimmunotherapy in patients with relapsed/refractory large B–cell lymphoma (r/r LBCL)1
Zamto–cel was ...
A Moonup Technology firma parceria com a Shelly, líder europeia em casas inteligentes, para apresentar um ecossistema completo de edifícios inteligentes na Taipei Building Show de 2025
TAIPEI, Taiwan, Dec. 06, 2025 (GLOBE NEWSWIRE) — A Moonup Technology Co., Ltd., parceira de operações em Taiwan da Shelly (Shelly Group), líder europeia em casas inteligentes, anunciou sua participação ...
Moonup Technology geht Partnerschaft mit dem europäischen Smart-Home-Marktführer Shelly ein, um auf der Taipei Building Show 2025 ein umfassendes Smart-Building-Ökosystem zu präsentieren
TAIPEI, Taiwan, Dec. 06, 2025 (GLOBE NEWSWIRE) — Moonup Technology Co., Ltd., der taiwanesische Partner des europäischen Smart–Home–Marktführers Shelly (Shelly Group), gab seine bedeutende Teilnahme an der Taipei ...
Moonup Technology s’associe à Shelly, le leader européen de la maison intelligente, pour présenter un écosystème complet de bâtiments intelligents au Taipei Building Show 2025
TAIPEI, Taïwan, 06 déc. 2025 (GLOBE NEWSWIRE) — Moonup Technology Co., Ltd., partenaire opérationnel taïwanais du leader européen de la maison intelligente Shelly (Shelly Group), a annoncé sa participation ...
MRX DEADLINE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Marex Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important December 8 Deadline in Securities Class Action – MRX
NEW YORK, Dec. 06, 2025 (GLOBE NEWSWIRE) —
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Marex Group plc (NASDAQ: MRX) between May 16, 2024 and August 5, 2025, both dates inclusive (the ...
MLTX IMPORTANT DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages MoonLake Immunotherapeutics Investors with Losses in Excess of $100K to Secure Counsel Before Important December 15 Deadline in Securities Class Action – MLTX
NEW YORK, Dec. 05, 2025 (GLOBE NEWSWIRE) —
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, both ...
ATYR DEADLINE MONDAY: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages aTyr Pharma, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important December 8 Deadline in Securities Class Action – ATYR
NEW YORK, Dec. 06, 2025 (GLOBE NEWSWIRE) —
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of aTyr Pharma, Inc. (NASDAQ: ATYR) between January 16, 2025 and September 12, 2025, both dates inclusive ...
WPP FINAL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages WPP plc Investors with Losses in Excess of $100K to Secure Counsel Before Important December 8 Deadline in Securities Class Action – WPP
NEW YORK, Dec. 05, 2025 (GLOBE NEWSWIRE) —
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Shares (“ADS” or “ADSs”) of WPP plc (NYSE: WPP) between February 27, ...
